2010
DOI: 10.1039/b926225n
|View full text |Cite
|
Sign up to set email alerts
|

Steroid-based anion receptors and transporters

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
82
0
2

Year Published

2010
2010
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 176 publications
(84 citation statements)
references
References 66 publications
0
82
0
2
Order By: Relevance
“…Consequently, the hydrophobic-hydrophilic balance of the compound is either increased or reduced, thus modifying its self-aggregation in aqueous solution. Several papers dealing with the physicochemical properties and applications in fields such as supramolecular chemistry, biomedicine, and pharmaceutics have been reported [18,[22][23][24][25][26][27][28].…”
Section: R1mentioning
confidence: 99%
“…Consequently, the hydrophobic-hydrophilic balance of the compound is either increased or reduced, thus modifying its self-aggregation in aqueous solution. Several papers dealing with the physicochemical properties and applications in fields such as supramolecular chemistry, biomedicine, and pharmaceutics have been reported [18,[22][23][24][25][26][27][28].…”
Section: R1mentioning
confidence: 99%
“…P. Davis and co-workers have continued their work on cholapods, which have previously been shown to be very powerful anion receptors and transporters. 97 In 2011 they reported the development of smaller cholapod-like receptors based on a central trans-decalin system 171a-i, which have the advantage of smaller molecular weights and decreased lipophilicity and are therefore more ''drug-like'' molecules. 98 1 H NMR titrations showed a strong 1 : 1 interaction between the receptors and tetraethylammonium chloride, and extraction techniques were used to estimate binding affinities of >10 6 M…”
mentioning
confidence: 99%
“…As the transport activity of 3 was only weak, this raises the concern that powerful anionophores might be highly toxic and thus unsuitable for CF treatment. We have developed a range of anionophores based on powerful anion binding sites created from hydrogen bond donor groups mounted on alicyclic scaffolds (see for example Figure 4 1) 10,27 . Scaffolds include steroids 18,28,29 , trans-decalins 30,31 and substituted cyclohexanes 32 , and the common design motif is the positioning of axially-directed H-bond donors in 1,5-relationships.…”
mentioning
confidence: 99%